Completed NA INTERVENTIONAL 1-arm NCT03375281

Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch Technique

Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch Technique: A Prospective Single Arm Study

Sponsor: Seoul National University Hospital

Conditions Hepatocellular Carcinoma Radiofrequency Ablation

Interventions RFA

Updated 9 times since 2018 Last updated: Mar 19, 2021 Started: Nov 20, 2017 Primary completion: Jan 28, 2020 Completion: Aug 21, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03375281, this NA trial focuses on Hepatocellular Carcinoma and Radiofrequency Ablation and remains completed. Sponsored by Seoul National University Hospital, it has been updated 9 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

9 versions recorded

Jan 2026 — Present [monthly]

Completed NA
Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Feb 2024 — Jul 2024 [monthly]

Completed NA

▶ Show 4 earlier versions

Apr 2021 — Feb 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Jan 2021 — Apr 2021 [monthly]

Unknown Status NA
Dec 2019 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2018 — Dec 2019 [monthly]

Recruiting NA

First recorded

Nov 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Seoul National University Hospital
Starmed

Data source: Seoul National University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea